RecruitingPhase 3ACTRN12608000419369

Arginine and wound healing in patients with critical limb ischaemia recovering from a bypass graft

The effectiveness of an Arginine-enriched diet in patients with critical limb ischaemia. Does it improve post-surgical outcomes?


Sponsor

Flinders University Faculty of Health Sciences

Enrollment

20 participants

Start Date

Aug 1, 2008

Study Type

Interventional

Conditions

Summary

Patients with critical lower-limb ischaemia admitted to RGH for a bypass graft will be invited to participate in a study investigating the effect of a diet that is enriched with arginine on the time taken for the surgical wound to heal. Participants will be allocated at random to receive either a standard hospital diet with 2 Arginine-enriched supplements or a standard hospital diet with 2 standard nutritional supplements, that are equal in energy, protein, vitamins and minerals. In addition to the time taken for the wound to heal, participants will also have their nutritional health measured via body weight, dietary intake and arm muscle stores. Quality of life will also be measured.


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 100 Yearss

Inclusion Criteria1

  • All patients with chronic critical lower-limb ischaemia admitted to the Vascular unit at the Repatriation General Hospital for a bypass graft procedure.

Exclusion Criteria1

  • Patients receiving palliative care and ICU (intensive care unit) patients. Patients who are nil by mouth or who require enteral feeding or parenteral nutrition. Patients who are unable to fulfill the requirements of the study due to impaired cognition

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Standard hospital diet plus two tetrapaks of a commercially available Arginie-enriched oral nutrition supplement (9g Arginine/day). The intervention will commence on entry to the study and will cease

Standard hospital diet plus two tetrapaks of a commercially available Arginie-enriched oral nutrition supplement (9g Arginine/day). The intervention will commence on entry to the study and will cease 30 days after the time of the bypass graft


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12608000419369